Clinical trials
Phase 1/2 Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 7 |
| Unknown status | 4 |
| Terminated | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Myeloma Network B.V. | 2 |
| University of Florida | 2 |
| Anaveon AG | 1 |
| Anbogen Therapeutics, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Biomoda Inc. | 1 |
| Chimagen Biosciences, Ltd | 1 |
| Chinese PLA General Hospital | 1 |
| Columbia University | 1 |
| Essen Biotech | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 29 |
| Breast Neoplasms | 3 |
| Leukemia | 3 |
| Multiple Myeloma | 3 |
| Carcinoma, Hepatocellular | 2 |
| Cardiovascular Diseases | 2 |
| Colorectal Neoplasms | 2 |
| Hematologic Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.